[Ophthalmologic monitoring in chloroquine therapy].
Eggers
I
I
Krastel
H
H
D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002738:Chloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D016903:Drug Monitoring; D006801:Humans; D010348:Patient Care Team; D012164:Retinal Diseases / Q000139:chemically induced* / Q000517:prevention & control
D000962:Antimalarials; D018501:Antirheumatic Agents; D002738:Chloroquine